These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 8058069)

  • 41. LLC-PK1 cell growth is repressed by WT1 inhibition of G-protein alpha i-2 protooncogene transcription.
    Kinane TB; Finder JD; Kawashima A; Brown D; Abbate M; Fredericks WJ; Sukhatme VP; Rauscher FJ; Ercolani L
    J Biol Chem; 1995 Dec; 270(51):30760-4. PubMed ID: 8530517
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transcriptional repression mediated by the WT1 Wilms tumor gene product.
    Madden SL; Cook DM; Morris JF; Gashler A; Sukhatme VP; Rauscher FJ
    Science; 1991 Sep; 253(5027):1550-3. PubMed ID: 1654597
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Stimulation of the murine type II transforming growth factor-beta receptor promoter by the transcription factor Egr-1.
    Wilder PJ; Bernadt CT; Kim JH; Rizzino A
    Mol Reprod Dev; 2002 Nov; 63(3):282-90. PubMed ID: 12237943
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor WT1.
    Drummond IA; Madden SL; Rohwer-Nutter P; Bell GI; Sukhatme VP; Rauscher FJ
    Science; 1992 Jul; 257(5070):674-8. PubMed ID: 1323141
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nerve growth factor induces transcription of transforming growth factor-beta 1 through a specific promoter element in PC12 cells.
    Kim SJ; Park K; Rudkin BB; Dey BR; Sporn MB; Roberts AB
    J Biol Chem; 1994 Feb; 269(5):3739-44. PubMed ID: 8106419
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The WT1 gene product stabilizes p53 and inhibits p53-mediated apoptosis.
    Maheswaran S; Englert C; Bennett P; Heinrich G; Haber DA
    Genes Dev; 1995 Sep; 9(17):2143-56. PubMed ID: 7657166
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Coordinate expression and distinct DNA-binding characteristics of the four EGR-zinc finger proteins in Jurkat T lymphocytes.
    Skerka C; Decker EL; Zipfel PF
    Immunobiology; 1997 Dec; 198(1-3):179-91. PubMed ID: 9442390
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Wnt-4 regulation by the Wilms' tumour suppressor gene, WT1.
    Sim EU; Smith A; Szilagi E; Rae F; Ioannou P; Lindsay MH; Little MH
    Oncogene; 2002 May; 21(19):2948-60. PubMed ID: 12082525
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differential regulation of the Wilms' tumor gene, WT1, during differentiation of embryonal carcinoma and embryonic stem cells.
    Scharnhorst V; Kranenburg O; van der Eb AJ; Jochemsen AG
    Cell Growth Differ; 1997 Feb; 8(2):133-43. PubMed ID: 9040935
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Repression of the c-myb gene by WT1 protein in T and B cell lines.
    McCann S; Sullivan J; Guerra J; Arcinas M; Boxer LM
    J Biol Chem; 1995 Oct; 270(40):23785-9. PubMed ID: 7559553
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In situ expression of the early growth response gene-1 during murine nephrogenesis.
    Rackley RR; Kessler PM; Campbell C; Williams BR
    J Urol; 1995 Aug; 154(2 Pt 2):700-5. PubMed ID: 7609158
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Elevated Egr-1 in human atherosclerotic cells transcriptionally represses the transforming growth factor-beta type II receptor.
    Du B; Fu C; Kent KC; Bush H; Schulick AH; Kreiger K; Collins T; McCaffrey TA
    J Biol Chem; 2000 Dec; 275(50):39039-47. PubMed ID: 10982796
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Wilms' tumor protein WT1 as an ovarian transcription factor: decreases in expression during follicle development and repression of inhibin-alpha gene promoter.
    Hsu SY; Kubo M; Chun SY; Haluska FG; Housman DE; Hsueh AJ
    Mol Endocrinol; 1995 Oct; 9(10):1356-66. PubMed ID: 8544844
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Novel replication inhibitory function of the developmental regulator/transcription repressor protein WT1 encoded by the Wilms' tumor gene.
    Anant S; Axenovich SA; Madden SL; Rauscher FJ; Subramanian KN
    Oncogene; 1994 Nov; 9(11):3113-26. PubMed ID: 7936634
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differential function of Wilms' tumor gene WT1 splice isoforms in transcriptional regulation.
    Hewitt SM; Fraizer GC; Wu YJ; Rauscher FJ; Saunders GF
    J Biol Chem; 1996 Apr; 271(15):8588-92. PubMed ID: 8621487
    [TBL] [Abstract][Full Text] [Related]  

  • 56. WT1 modulates apoptosis by transcriptionally upregulating the bcl-2 proto-oncogene.
    Mayo MW; Wang CY; Drouin SS; Madrid LV; Marshall AF; Reed JC; Weissman BE; Baldwin AS
    EMBO J; 1999 Jul; 18(14):3990-4003. PubMed ID: 10406804
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Repression of the retinoic acid receptor-alpha gene by the Wilms' tumor suppressor gene product, wt1.
    Goodyer P; Dehbi M; Torban E; Bruening W; Pelletier J
    Oncogene; 1995 Mar; 10(6):1125-9. PubMed ID: 7700638
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Wilms' tumor suppressor gene WT1 is negatively autoregulated.
    Rupprecht HD; Drummond IA; Madden SL; Rauscher FJ; Sukhatme VP
    J Biol Chem; 1994 Feb; 269(8):6198-206. PubMed ID: 8119964
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The transcriptional effect of WT1 is modulated by choice of expression vector.
    Reddy JC; Hosono S; Licht JD
    J Biol Chem; 1995 Dec; 270(50):29976-82. PubMed ID: 8530399
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transcriptional regulation of the AP-2alpha promoter by BTEB-1 and AP-2rep, a novel wt-1/egr-related zinc finger repressor.
    Imhof A; Schuierer M; Werner O; Moser M; Roth C; Bauer R; Buettner R
    Mol Cell Biol; 1999 Jan; 19(1):194-204. PubMed ID: 9858544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.